Multiple sclerosis: understand everything
about this neurological disease
Causes, symptoms, progressive forms, diagnosis and management — a complete guide for patients, relatives and healthcare professionals
Multiple sclerosis (MS) is one of the most common neurological diseases among young adults. A chronic autoimmune disease of the central nervous system, it affects approximately 120,000 people in France and still raises many questions, fears, and misconceptions today. This comprehensive guide aims to help you deeply understand what MS really is: its biological mechanisms, its multiple clinical faces, the challenges of diagnosis, the treatments available in 2026, and above all, the concrete resources to support patients and their loved ones on a daily basis.
1. What is multiple sclerosis? Definition and mechanisms
The term "multiple sclerosis" may seem mysterious. It actually refers to a precise anatomical reality: plaques of demyelination — that is, areas where the myelin, the protective sheath of nerve fibers, has been damaged — scattered throughout the brain and spinal cord. These scars (sclerosis) give the disease its name.
1.1 Myelin: understanding why it's central
To understand MS, one must understand the role of myelin. This fatty substance surrounds axons (extensions of neurons) and acts as an insulating electrical cable: it accelerates and ensures the reliability of nerve impulse transmission. Without intact myelin, nerve signals slow down, disperse, or fail to reach their destination.
In MS, the immune system mistakenly attacks this myelin — this is the definition of an autoimmune disease. Immune cells (mainly T lymphocytes) cross the blood-brain barrier and cause inflammation that gradually destroys the myelin sheath, and sometimes the axons themselves. The result: disturbances in the transmission of nerve signals, which manifest as the very varied symptoms characteristic of MS.
🧬 MS: an autoimmune disease, not contagious
MS is not contagious, does not transmit from one person to another and is not directly hereditary in the strict sense. It results from a complex interaction between a genetic predisposition (several genes involved, including HLA-DRB1) and triggering environmental factors. Having a parent with MS increases the risk, but does not make it certain.
1.2 Why "plaques"?
The term "plaques" refers to the visible lesions on MRI — areas of demyelination that appear as white spots on brain images. These plaques are disseminated in space (they are found in several places in the brain and spinal cord) and disseminated in time (they appear at different times). This double dissemination — spatial and temporal — actually forms the basis of the modern diagnosis of MS.
2. The causes of MS: what research has identified
After decades of research, multiple sclerosis is now better understood, even though no single definitive cause has been identified. MS results from an interaction between genetic, immunological, and environmental factors.
2.1 Genetic factors
MS is not a genetic disease in the classical sense — there is no unique "MS gene." However, a genetic predisposition is clearly established. The risk of developing MS is about 0.1% in the general population, but rises to 2-3% if a first-degree relative is affected, and to 25-30% in monozygotic twins (identical twins). More than 200 genetic variants have been associated with susceptibility to MS, most involved in the regulation of the immune system.
2.2 Environmental factors: the main suspects
Vitamin D deficiency
Vitamin D plays a major immunoregulatory role. Regions far from the equator, with less sunshine, have a significantly higher prevalence of MS. Studies show that low vitamin D levels increase the risk of MS and are associated with higher disease activity.
Epstein-Barr Virus (EBV)
Very strong recent studies (notably on millions of American military personnel) establish a strong link between infection with the EBV (responsible for mononucleosis) and the development of MS. This mechanism is the subject of intense research in 2026.
Smoking
Tobacco is a recognized risk factor, which increases both the likelihood of developing MS and its rate of progression. It also reduces the effectiveness of immunomodulatory treatments.
Gut microbiome
Disruptions of the gut microbiome (dysbiosis) have been observed in MS patients. The link between the gut-brain axis and autoimmune inflammation is a major research area that could open new therapeutic avenues.
The mystery of latitude: MS is significantly more common in Nordic countries (Scandinavia, Scotland, Canada) than in tropical countries. In France, the prevalence is higher in Alsace than in Corsica. This geographical distribution directs researchers towards sunlight, vitamin D, and infectious factors as keys to understanding the disease.
3. The different forms of MS
MS is not a uniform disease. It presents in several evolving forms, which differ in their relapse profile, rate of progression, and therapeutic implications.
| Form | Evolving profile | Frequency | Treatment |
|---|---|---|---|
| Relapsing-remitting MS (RRMS) | Relapses with partial or total recovery between episodes | 85% of cases at diagnosis | Very effective disease-modifying treatments available |
| Secondarily progressive MS (SPMS) | Initial relapsing phase, then continuous progression with or without relapses | 50% of RRMS after 10-15 years | Limited but expanding options |
| Primarily progressive MS (PPMS) | Continuous progression from the start, without distinct relapses | 10-15% of cases | Ocrelizumab approved since 2018 |
| Progressive-relapsing MS | Continuous progression with superimposed relapses | Rare | Combined approach |
| Clinically isolated syndrome (CIS) | First neurological episode, not yet established MS | Possible precursor | Monitoring and early treatment discussed |
⚠️ Benign MS: a concept to nuance. For a long time, "benign MS" was used to describe forms with few relapses and little disability over 10-15 years. This concept is now being questioned: long-term follow-up studies show that even seemingly benign forms can evolve into progressive disability, and that cognitive disorders may be present while mobility is intact.
4. Symptoms of multiple sclerosis
MS is often called "the disease with a thousand faces" as its symptoms are varied, unpredictable, and different from one person to another. They depend on the location of the plaques in the brain and spinal cord. Some are visible from the outside, while others — the "invisible symptoms" — are often unknown or misunderstood by those around.
4.1 Motor symptoms
Motor disorders are among the most visible manifestations of MS. They include weakness or paralysis of one or more limbs (hemiparesis, paraparesis), balance and coordination disorders (ataxia), spasms, and muscle spasticity, as well as intention tremors. These symptoms directly affect mobility, walking, and daily activities.
4.2 Sensory disorders
Tingling, numbness, burning sensations or tightness, neuropathic pain are part of the frequent sensory symptoms in MS. Lhermitte's sign — a sensation of electricity descending the spine when bending the neck — is characteristic of MS, even though it is not specific.
4.3 Visual disorders
Optic neuritis — inflammation of the optic nerve — is often the first sign of MS. It manifests as a decrease in unilateral visual acuity, pain with eye movement, and alteration of color vision. In most cases, recovery is good, but some sequelae may persist. Diplopia (double vision) due to involvement of the eye muscles is also common.
Fatigue — the invisible symptom #1
MS fatigue is unique: profound, overwhelming, not correlated with effort, it can occur suddenly even after a night of sleep. It affects 80% of patients and is often the most disabling symptom in daily life, yet little visible from the outside.
Cognitive disorders
50 to 70% of MS patients experience cognitive disorders: slowing of information processing, difficulties with episodic and working memory, concentration issues, and executive function problems. These symptoms are often poorly recognized but have a significant impact on professional and social life.
Uhthoff's phenomenon
The temporary worsening of symptoms in heat (hot bath, fever, intense exercise) is characteristic of MS. It is due to the increased sensitivity of demyelinated fibers to heat. This phenomenon is not a relapse — symptoms regress with cooling.
Bladder and sphincter disorders
Urinary urgency, incontinence, difficulties urinating, constipation — bladder and sphincter disorders affect 70 to 80% of patients at some point in their illness. They have a major impact on quality of life and are often addressed late due to embarrassment.
DYNSEO Emotion Thermometer
MS is often accompanied by emotional fluctuations that are difficult to verbalize. The emotion thermometer allows patients and caregivers to identify and communicate the emotional state of the day, thus facilitating mutual understanding and therapeutic follow-up.
Discover the tool4.4 Psychological and emotional symptoms
MS does not only affect the body. Mood disorders — depression, anxiety, emotional lability — are common and multifactorial: they can result directly from brain lesions in the areas of emotional regulation, from the psychological reaction to a chronic disabling illness, or from the side effects of certain treatments.
Depression affects about 50% of MS patients during their lifetime — a rate significantly higher than that observed in other comparable chronic diseases. It must be systematically screened and treated, as it significantly worsens quality of life and can impact adherence to treatments.
5. What is an MS relapse?
In relapsing-remitting MS, the disease progresses through relapses — episodes of onset or worsening of neurological symptoms. Understanding what a relapse is, how to recognize it, and how to react is essential for patients and their loved ones.
Definition of a relapse
A relapse is defined as the onset or worsening of neurological symptoms lasting at least 24 hours, in the absence of fever or infection, separated by at least 30 days from the previous relapse. It corresponds to new active inflammation in the central nervous system.
Duration and recovery
A relapse generally lasts from a few days to a few weeks. Recovery is often good, especially in the early years of the disease, but can be partial. Each relapse can leave varying sequelae — this is why early treatment of severe relapses is important.
Treatment of relapses
Severe relapses are treated with high-dose corticosteroid infusions (methylprednisolone), which accelerate recovery without altering the long-term prognosis. This treatment should only be used for truly disabling relapses.
6. The diagnosis of multiple sclerosis
The diagnosis of MS is a pivotal moment in a person's life. It currently relies on the McDonald criteria 2017, which integrate clinical, MRI, and biological data to make the diagnosis with maximum precision and minimum delay.
6.1 MRI: the key examination
Cerebral and spinal MRI is the reference examination in MS. It allows visualization of demyelination plaques, localization, dating (active lesions enhance after gadolinium injection), and monitoring their evolution. A brain with "black hole" lesions (old plaques) and recent lesions indicates active disease.
6.2 Lumbar puncture and evoked potentials
The lumbar puncture, which analyzes cerebrospinal fluid (CSF), can reveal oligoclonal bands of IgG — present in 85-90% of MS cases — and other inflammatory markers. Visual, auditory, or sensory evoked potentials measure nerve conduction speed and can detect clinically silent lesions.
Training — Understanding MS: essential guide for relatives
An accessible and supportive training to help relatives understand the disease, its mechanisms, symptoms, and evolution — to better support without exhausting themselves.
Access the training →7. Treatments for multiple sclerosis in 2026
The therapeutic management of MS has significantly progressed since the 1990s. Today, a wide arsenal of medications allows for reducing the frequency of relapses, slowing progression, and preventing lesions. However, there is still no curative treatment.
7.1 Disease-modifying treatments (DMT)
Disease-Modifying Therapies (DMT) aim to reduce inflammatory activity and prevent new relapses. They are divided into three levels of efficacy:
| Level | Main molecules | Effectiveness on outbreaks | Administration |
|---|---|---|---|
| 1st line (moderate) | Beta interferon, Glatiramer acetate, Dimethyl fumarate, Teriflunomide | -30 to -50 % | Injectable or oral |
| 2nd line (high effectiveness) | Natalizumab, Fingolimod, Siponimod, Ozanimod | -60 to -70 % | Injectable or oral |
| 3rd line (very high effectiveness) | Alemtuzumab, Ocrelizumab, Ofatumumab, Cladribine | -70 to -90 % | Infusion or oral |
7.2 Rehabilitation and non-drug management
Rehabilitation plays a central role in the management of MS. Physiotherapy, occupational therapy, speech therapy (for swallowing or speech disorders), neuropsychology, psychology — each specialty contributes to maintaining functional abilities and quality of life. Adapted physical activity, long discouraged for fear of worsening symptoms, is now recognized as beneficial at all stages of the disease.
DYNSEO session follow-up sheet
The session follow-up sheet allows healthcare professionals (physiotherapist, occupational therapist, psychomotor therapist) to track the exercises performed, the progress observed, and the goals for the next session — a valuable continuity tool in the follow-up of MS patients.
Download the sheet8. Cognitive disorders in MS: the hidden side of the disease
Cognitive disorders are one of the most poorly recognized and least well-managed manifestations of MS. Yet, they affect more than half of patients and have a considerable impact on professional, family, and social life.
8.1 What cognitive disorders in MS?
Cognitive slowing
Slower information processing. Complex tasks take longer, even if performed correctly.
Episodic memory
Difficulties in memorizing new information and retrieving it later. Procedural memory is often better preserved.
Sustained attention
Difficulties in maintaining concentration on a long task, filtering out distractors, doing two things at once.
Executive functions
Planning, organization, mental flexibility, and decision-making difficulties under time pressure.
8.2 Cognitive stimulation: an essential lever
Regular cognitive stimulation is now recognized as a lever for maintaining intellectual capacities in MS. It does not heal existing lesions, but it promotes brain plasticity — the brain's ability to create new compensatory circuits — and can slow cognitive decline.
The CLINT app from DYNSEO is specially designed for adults with cognitive disorders, particularly in the context of neurological pathologies like MS. Its activities — memory, attention, language, logic — are adapted in difficulty, progressive, and accessible even for individuals experiencing significant cognitive fatigue.
DYNSEO Motivation Chart
Maintaining regularity in cognitive stimulation can be difficult with fatigue related to MS. The motivation chart helps visualize goals, celebrate progress, and maintain engagement in cognitive activities on a daily basis.
Access the chartTraining — Fatigue and cognitive disorders in MS
Understanding the mechanisms of fatigue and cognitive disorders in MS, identifying compensatory strategies and suitable stimulation tools — for patients as well as for relatives and caregivers.
Discover the training →9. Living with MS: daily life, work, and relationships
MS is a disease that settles into daily life. It disrupts projects, relationships, and professional and personal identity. Understanding these dimensions is essential to provide comprehensive and humane support.
9.1 MS and professional life
MS primarily affects young adults in full professional activity. Fatigue, cognitive disorders, unpredictable flare-ups, frequent medical appointments — maintaining professional activity often constitutes a major challenge. Yet, working remains possible and desirable for the vast majority of patients, especially with suitable accommodations.
🏢 Workplace accommodations
- Partial or total telecommuting
- Adjusted hours (morning fatigue or nap)
- Adapted position (ergonomic desk, chair)
- Disability recognition for access to AGEFIPH aids
- Therapeutic part-time work if necessary
- Cognitive assistance software
💬 To tell or not to tell the employer?
- No legal obligation to disclose MS
- The occupational physician, medical confidentiality guaranteed
- Disability recognition possible without revealing the diagnosis
- MS France Association: legal advice
- Cap Emploi: tailored professional support
- Each situation is unique — personal decision
9.2 MS, couple and surroundings
MS affects the surroundings as much as the patient. Loved ones — especially the partner — may find themselves in an unchosen caregiver role, with the risks of burnout that this entails. Communication within the couple transforms, sometimes leading to a rupture of the intimate balance.
Expressing what one feels, naming the invisible fatigue, discussing fears and mutual expectations without waiting for a crisis — this is the challenge that many couples facing MS take on. Psychological support for both members of the couple is often valuable.
3-column table — structuring thoughts and emotions
The 3-column table from DYNSEO is a tool for cognitive and emotional structuring. It helps organize thoughts, identify obstacles and solutions — particularly useful for MS patients facing planning and prioritization difficulties.
Use the toolTraining — Living with long-term MS: caregiver, couple, and future
A training designed for caregivers and couples: understanding the impact of MS on relational dynamics, preventing caregiver burnout, and building a shared life project despite the disease.
Access the training →10. MS in institutions: supporting advanced forms
In the progressive or advanced forms of MS, some patients are cared for in medico-social establishments (Nursing home, MAS, FAM) or benefit from intensive home care. Support in these contexts requires specific training for healthcare professionals.
Healthcare providers facing MS in institutions must understand the particularities of the disease: the variability of symptoms from day to day, the impact of heat on capacities, the cognitive fatigue that is not always visible, the often underestimated bladder and sphincter disorders, and the central psychological dimension of support.
Training — MS in institutions: understanding and adapting practice
A training dedicated to healthcare professionals who support MS patients in institutions: understanding the specifics of the disease, adapting care, preventing complications, and maintaining autonomy as long as possible.
Discover the training →11. Maintaining autonomy: strategies and practical tools
Preserving autonomy is a central objective in supporting MS. This involves home adaptations, the use of technical aids, regular cognitive stimulation, and psychological support. But it also involves therapeutic education for the patient that allows them to understand their disease, recognize warning signs, and adapt their lifestyle.
11.1 Adapting the home and daily life
11.2 Cognitive stimulation in daily life
Regular cognitive exercises — reading, puzzles, strategy games, manual activities — help maintain brain plasticity and preserve intellectual abilities in MS. Digital stimulation programs like the CLINT app from DYNSEO offer structured, progressive, and accessible stimulation even on days of significant fatigue.
DYNSEO also offers a complete suite of online cognitive tests that allow for regular assessment of cognitive functions — memory, attention, processing speed — and early detection of any potential changes. These tools, used in conjunction with neuropsychological monitoring, provide a valuable dashboard for both the patient and the care team.
Training — MS and daily life: maintaining autonomy
All the practical strategies to adapt daily life to MS, prevent complications, manage fatigue, and maintain autonomy for as long as possible — for patients and caregivers.
Access the training →12. Research on MS in 2026: concrete hopes
MS is one of the neurological diseases where research is progressing the fastest. In 2026, several research avenues open up truly promising perspectives for patients.
12.1 Remyelination therapies
So far, available treatments mainly act on inflammation to prevent new lesions. But they do not allow for the repair of already destroyed myelin. Remyelination therapies — which aim to stimulate precursor cells of oligodendrocytes to rebuild the damaged myelin sheath — represent the next great hope. Several molecules are in advanced clinical trials.
12.2 Neuroprotection
Alongside remyelination, neuroprotective therapies seek to preserve axons from damage caused by chronic inflammation. The progression of disability in progressive forms is largely related to irreversible axonal loss — this is the aspect that neuroprotective therapies aim to prevent.
12.3 The role of the microbiome and new therapeutic targets
The growing understanding of the role of the gut microbiome in MS paves the way for unprecedented therapeutic approaches: targeted probiotics, anti-inflammatory diets, and even fecal microbiota transplantation in research contexts. These experimental avenues illustrate the paradigm shift towards a more systemic view of the disease.
The EBV-MS link: The very strong demonstration of the link between Epstein-Barr virus infection and the subsequent development of MS has rekindled hopes for a preventive vaccine. If an anti-EBV vaccine proves effective in preventing mononucleosis, it could also reduce the incidence of MS — a prospect that mobilizes several global research teams.
13. Resources, associations, and support for MS patients
Being diagnosed with MS means joining a community of patients, loved ones, and professionals committed to fighting the disease. Many resources exist to ensure you do not go through this ordeal alone.
13.1 Leading associations in France
ARSEP
The Foundation for Research Aid on MS funds research and publishes validated medical information. It organizes fundraising events and provides educational resources for patients and their families.
MS France (formerly LFSEP)
The French League Against Multiple Sclerosis supports patients in their administrative and social processes, offers local support groups, and provides legal and professional assistance.
OFSEP
The French Observatory of MS is a national cohort that follows thousands of patients over time. Participation in OFSEP contributes to research and allows patients to benefit from enhanced monitoring in expert centers.
Monitoring Applications
Dedicated applications allow patients to record their symptoms, fatigue levels, relapses, and treatments. This digital health journal is valuable during neurological consultations.
13.2 Patient Therapeutic Education (PTE)
Patient therapeutic education is a recognized right for people with chronic diseases. For MS patients, PTE programs are offered in reference centers: they learn to understand their disease, manage fatigue, recognize relapses, adapt their lifestyle, and communicate with caregivers. These programs significantly improve treatment adherence and quality of life.
DYNSEO's online training complements these initiatives by providing flexible and accessible access to quality information, whether for the patients themselves, their relatives, or the healthcare professionals who support them. The training Essential Guide for Relatives is particularly suitable for families looking to understand without getting lost in medical jargon.
« Understanding MS is not resigning oneself to the disease. It is giving oneself the means to live with it differently — with more serenity, more anticipation, and more humanity in the caregiver-patient relationship. »
— Perspective of multidisciplinary teams in neurology13.3 Nutrition, lifestyle, and psychological support
If no diet has been scientifically proven as a treatment for MS, several data converge on the importance of an anti-inflammatory diet. The Mediterranean diet — rich in vegetables, fruits, fatty fish, olive oil, and legumes — is associated with better neurological health. Vitamin D supplementation is widely recommended for MS patients in consultation with the neurologist, as many patients have documented deficiencies. Stress management, quality sleep, and adapted physical activity are the other pillars of a favorable lifestyle.
Psychological support is an essential component of the overall management of MS, not a luxury. Living with an unpredictable chronic illness generates a real psychological burden: mourning for the life before, fear of the future, uncertainty about the progression, questioning one's professional and personal identity. Neuropsychologists play a particularly important role in supporting cognitive disorders related to MS: they precisely assess the cognitive profile, propose suitable compensation strategies, and assist the patient in managing their daily difficulties. In parallel, the regular use of cognitive stimulation tools like the CLINT app from DYNSEO helps maintain structured cognitive activity between professional follow-up sessions.
Finally, the online cognitive tests offered by DYNSEO on the our-tests page are a valuable monitoring tool: they allow the patient and their care team to track the evolution of cognitive functions over time, to detect any deterioration early, and to adjust stimulation programs accordingly. This proactive approach, combining medical follow-up and self-management, is at the heart of the new way to support MS in 2026.
🌟 The essential message for patients and their loved ones
MS is a serious disease that deserves serious care. But it does not define a person in their entirety. Tens of thousands of people with MS lead active professional lives, fulfilling relationships, family projects, and rich community engagements. The secret: to inform oneself without drowning, to surround oneself without isolating, to care for oneself without reducing oneself to their illness. DYNSEO supports this approach with accessible training, practical tools, and a caring philosophy: every person deserves to be supported with the right tools, at the right time, at their own pace.
It is important to emphasize that MS affects people in the prime of their lives, often in the midst of building their life — professional, family, personal. This context makes psychological, social, and practical support even more crucial. Loved ones, caregivers, and employers have a decisive role to play so that people with MS can continue to thrive, contribute, and envision the future. Informing, training, equipping, and supporting: this is the mission that DYNSEO pursues through its training, free tools, and cognitive stimulation applications, in service of patients and all those around them. Understanding of MS progresses each year, and with it, hopes for increasingly effective treatments to preserve quality of life and slow down disability. Staying informed, active, and surrounded remains the best strategy against this complex but increasingly manageable disease.
What to remember about MS
Multiple sclerosis is a complex, unpredictable disease, but it is increasingly well understood and treated. Early diagnosis, multidisciplinary care, and an adapted life allow the vast majority of patients to maintain their quality of life for a long time. MS is not a life on hold — it is a reinvented life, with the right tools and the right supporters by its side.
Explore DYNSEO's MS training →FAQ — Frequently Asked Questions about Multiple Sclerosis
Q1 Is multiple sclerosis fatal?
MS only slightly reduces life expectancy in the vast majority of cases — by 5 to 10 years according to the most recent studies, a gap that tends to narrow thanks to modern treatments. It is not a fatal disease in the short term. However, very severe forms and complications (recurrent urinary infections, pneumonia related to swallowing disorders) can be serious. MS can also lead to significant disability, which justifies early and active management.
Q2 Can you get pregnant when you have MS?
Yes, and pregnancy even has a protective effect on MS: relapses are less frequent during pregnancy, especially in the third trimester. However, the risk of relapse increases in the 3-6 months after childbirth. A pregnancy in a woman with MS should be planned and discussed with the neurologist, particularly to adjust the baseline treatment before conception and after childbirth. MS does not prevent becoming a mother.
Q3 What is the difference between a relapse and a pseudo-relapse?
A pseudo-relapse (or false relapse) is a temporary worsening of already existing symptoms, without new active inflammatory lesions. It is often triggered by heat (Uhthoff's phenomenon), an infection, a feverish state, or great fatigue. A true relapse involves new symptoms or a clear worsening of old symptoms, lasting more than 24 hours, without fever. The distinction is important because true relapses may require treatment with corticosteroids, while pseudo-relapses do not.
Q4 Can you engage in sports activities with MS?
Not only is it possible, but it is highly recommended. Regular and adapted physical activity improves fatigue, muscle strength, balance, sleep quality, mood, and even cognitive functions in MS. Swimming (in cool water), yoga, Pilates, indoor cycling, and Nordic walking are particularly well-suited. Intense efforts that significantly raise body temperature should be avoided. An adapted physical activity program (APA) with a professional is ideal.
Q5 How to help a loved one with MS without exhausting yourself?
Helping a loved one with MS is a valuable but demanding commitment. To avoid burnout, it is essential to accept external help (home services, caregiver relief), maintain personal spaces and activities for oneself, participate in support groups for caregivers, and educate oneself to better understand the disease. DYNSEO offers training dedicated to caregivers and couples: Living with MS in the long term. Taking care of oneself is not abandoning the other — it is the condition for being able to continue supporting them.
Did this content help you? Support DYNSEO 💙
We are a small team of 14 people based in Paris. For 13 years, we have been creating free content to help families, speech therapists, care homes and healthcare professionals.
Your feedback is the only way we know if our work is useful. A Google review helps us reach other families, caregivers and therapists who need it.
One action, 30 seconds: leave us a Google review ⭐⭐⭐⭐⭐. It costs nothing, and it changes everything for us.
